Editas Medicine (EDIT) EBT (2015 - 2025)
Editas Medicine's (EDIT) quarterly EBT came in at -$30.3 million in Q3 2025, up 51.28% year-on-year from -$20.0 million in Q3 2024, and up 41.75% on a QoQ basis from -$52.0 million in Q2 2025.
Editas Medicine (EDIT) EBT (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of EBT data on file, last reported at -$30.3 million in Q3 2025.
- On a quarterly basis, EBT rose 51.28% year-over-year to -$30.3 million in Q3 2025; TTM through Sep 2025 was -$219.2 million, a 1.52% decrease from a year earlier, with the FY2024 full-year figure at -$255.5 million, up 46.79% from the prior year.
- EBT for Q3 2025 stood at -$30.3 million, up from -$52.0 million in the prior quarter.
- Over the last five years, EBT for EDIT reached as high as -$20.4 million in Q4 2023 and fell as low as -$4.0 billion in Q1 2022.
- Historically, EBT has averaged -$444.9 million across 5 years, with a median of -$67.6 million in 2024.
- Across the five-year window, EBT tumbled 3901.13% in 2022 and jumped 92.91% in 2023, its largest moves.
- Year by year, EBT stood at -$33.7 million in 2021, then sank by 71.62% to -$57.9 million in 2022, then soared by 64.7% to -$20.4 million in 2023, then plunged by 184.76% to -$58.2 million in 2024, then soared by 47.95% to -$30.3 million in 2025.
- Per Business Quant data, the three most recent EBT figures were -$30.3 million in Q3 2025, -$52.0 million in Q2 2025, and -$78.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.27 Mn |
| Jun 30, 2025 | -51.96 Mn |
| Mar 31, 2025 | -78.85 Mn |
| Dec 31, 2024 | -58.16 Mn |
| Sep 30, 2024 | -62.14 Mn |
| Jun 30, 2024 | -67.61 Mn |
| Mar 31, 2024 | -65.80 Mn |
| Dec 31, 2023 | -20.42 Mn |
| Sep 30, 2023 | -132.82 Mn |
| Jun 30, 2023 | -506.50 Mn |
| Mar 31, 2023 | -283.96 Mn |
| Dec 31, 2022 | -57.87 Mn |
| Sep 30, 2022 | -1.59 Bn |
| Jun 30, 2022 | -1.11 Bn |
| Mar 31, 2022 | -4.01 Bn |
| Dec 31, 2021 | -33.72 Mn |
| Sep 30, 2021 | -67.50 Mn |
| Jun 30, 2021 | -130.67 Mn |
| Mar 31, 2021 | -100.10 Mn |
| Dec 31, 2020 | -67.65 Mn |